Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.62 USD | +0.59% | +0.63% | -36.54% |
Business Summary
Number of employees: 553
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Medicines
100.0
%
| 78 | 100.0 % | 9 | 100.0 % | -88.02% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 78 | 100.0 % | 9 | 100.0 % | -88.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 01/15/01 |
Charles Homcy
FOU | Founder | 75 | 01/15/01 |
Founder | 73 | 01/15/01 | |
Brian Stephenson
DFI | Director of Finance/CFO | 43 | 01/18/01 |
Jonathan Fox
PSD | President | 67 | - |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/16/01 |
Christine Siu
COO | Chief Operating Officer | 47 | 01/20/01 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Vikram Bali
IRC | Investor Relations Contact | - | - |
Adora Ndu
LAW | General Counsel | 43 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 01/16/01 |
Founder | 73 | 01/15/01 | |
Fred Hassan
BRD | Director/Board Member | 78 | 17/21/17 |
Charles Homcy
FOU | Founder | 75 | 01/15/01 |
Randal Scott
BRD | Director/Board Member | 66 | 23/20/23 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Douglas Dachille
BRD | Director/Board Member | 59 | 17/21/17 |
Ali Satvat
BRD | Director/Board Member | 46 | 01/16/01 |
Andrew Lo
FOU | Founder | 63 | 01/15/01 |
Neil Kumar
FOU | Founder | 45 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 193,321,021 | 144,456,085 ( 74.72 %) | 6,191,761 ( 3.203 %) | 74.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LIANBIO 4.75% | 5,002,792 | 4.75% | 1,615,902 $ |
Company contact information
BridgeBio Pharma, Inc.
3160 Porter Drive Suite 250
94304, Palo Alto
+650 391 9740
http://www.bridgebio.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.54% | 4.77B | |
-4.22% | 87.17B | |
+2.76% | 40.1B | |
-16.98% | 31.38B | |
+57.86% | 25.12B | |
-16.24% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.10% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- BBIO Stock
- Company BridgeBio Pharma, Inc.